BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 37395506)

  • 21. Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study.
    Sato S; Shimizu Y; Goto T; Kitahara A; Koike T; Ishikawa H; Watanabe T; Tsuchida M
    BMC Pulm Med; 2018 Aug; 18(1):134. PubMed ID: 30097033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.
    Tzouvelekis A; Karampitsakos T; Gomatou G; Bouros E; Tzilas V; Manali E; Tomos I; Trachalaki A; Kolilekas L; Korbila I; Tomos P; Chrysikos S; Gaga M; Daniil Z; Bardaka F; Papanikolaou IC; Euthymiou C; Papakosta D; Steiropoulos P; Ntolios P; Tringidou R; Papiris S; Antoniou K; Bouros D
    Pulm Pharmacol Ther; 2020 Feb; 60():101880. PubMed ID: 31874284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management.
    van Cleemput J; Sonaglioni A; Wuyts WA; Bengus M; Stauffer JL; Harari S
    Adv Ther; 2019 Feb; 36(2):298-317. PubMed ID: 30554332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research Progress in the Pathogenesis of Idiopathic Pulmonary Fibrosis with Lung Cancer].
    Liu C; He Y
    Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):695-700. PubMed ID: 32838491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research Progress on Pathogenic Mechanism and Potential Therapeutic Drugs of 
Idiopathic Pulmonary Fibrosis Complicated with Non-small Cell Lung Cancer].
    Xiao T; Bao J; Liu X; Huang H; Zhou H
    Zhongguo Fei Ai Za Zhi; 2022 Oct; 25(10):756-763. PubMed ID: 36167462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
    Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
    BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.
    Gershman E; Zer A; Pertzov B; Shtraichman O; Shitenberg D; Heching M; Rosengarten D; Kramer M
    BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis.
    Aiello M; Bertorelli G; Bocchino M; Chetta A; Fiore-Donati A; Fois A; Marinari S; Oggionni T; Polla B; Rosi E; Stanziola A; Varone F; Sanduzzi A
    Pulm Pharmacol Ther; 2017 Jun; 44():7-15. PubMed ID: 28257817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of Older Patients with Pulmonary Fibrosis and Non-Small Cell Lung Cancer.
    Whittaker Brown SA; Padilla M; Mhango G; Taioli E; Powell C; Wisnivesky J
    Ann Am Thorac Soc; 2019 Aug; 16(8):1034-1040. PubMed ID: 30990757
    [No Abstract]   [Full Text] [Related]  

  • 30. Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience.
    Rivera-Ortega P; Hayton C; Blaikley J; Leonard C; Chaudhuri N
    Ther Adv Respir Dis; 2018; 12():1753466618800618. PubMed ID: 30249169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer.
    Goto T; Maeshima A; Oyamada Y; Kato R
    Int J Clin Oncol; 2014 Apr; 19(2):266-73. PubMed ID: 23660786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis.
    Saito Y; Kawai Y; Takahashi N; Ikeya T; Murai K; Kawabata Y; Hoshi E
    Ann Thorac Surg; 2011 Nov; 92(5):1812-7. PubMed ID: 21944440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function.
    Zhang X; Li W; Li C; Zhang J; Su Z
    BMC Pulm Med; 2021 Apr; 21(1):122. PubMed ID: 33858421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update on current and emerging drug treatments for idiopathic pulmonary fibrosis.
    Trachalaki A; Sultana N; Wells AU
    Expert Opin Pharmacother; 2023; 24(10):1125-1142. PubMed ID: 37183672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort.
    Durheim MT; Bendstrup E; Carlson L; Sutinen EM; Hyldgaard C; Kalafatis D; Myllärniemi M; Sköld CM; Sjåheim T
    Respirology; 2021 Oct; 26(10):982-988. PubMed ID: 34291523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative pirfenidone treatment as prophylaxis against acute exacerbation of idiopathic pulmonary fibrosis: a single-center analysis.
    Sekihara K; Aokage K; Miyoshi T; Tane K; Ishii G; Tsuboi M
    Surg Today; 2020 Aug; 50(8):905-911. PubMed ID: 32144483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of patients with small cell lung cancer and idiopathic pulmonary fibrosis treated with chemotherapy or chemoradiotherapy.
    Kanaji N; Shimizu J; Sakai K; Ueda Y; Miyawaki H; Watanabe N; Uemura T; Hida T; Inoue T; Watanabe N; Oohara Y; Dobashi H; Kato M; Kadowaki N
    Ther Adv Respir Dis; 2020; 14():1753466620963866. PubMed ID: 33086985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of nintedanib, an inhibitor of tyrosine kinases, in patients with non-small cell lung cancer or idiopathic pulmonary fibrosis.
    Schmid U; Liesenfeld KH; Fleury A; Dallinger C; Freiwald M
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):89-101. PubMed ID: 29119292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expert Knowledge and Supporting Advice for the Clinical Use of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis].
    Behr J; Günther A; Kreuter M; Koschel D; Prasse A; Pfeifer M; Costabel U
    Pneumologie; 2017 Sep; 71(9):567-579. PubMed ID: 28772332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection.
    Nezka H; Igor P; Izidor K
    Radiol Oncol; 2019 Sep; 53(3):357-361. PubMed ID: 31553706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.